Preferential killing of p53-deficient cancer cells by reversine. (Q54510509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Preferential killing of p53-deficient cancer cells by reversine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

ChEBI release 2020-05-28

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mohamed Jemaà

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Francesco Berardinelli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Maria Castedo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ilio Vitale

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Lorenzo Galluzzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

13

Guido Kroemer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

Oliver Kepp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

8

Gérard Pierron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

Delphine Lissa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

10

Antonio Antoccia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Alice Boilève

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Francis Harper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Cell Cycle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

2149-2158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22592527%20AND%20SRC:MED&resulttype=core&format=json

p53 Research: the past thirty years and the next thirty years.

1 February 2020

cites work

1 reference

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

21 January 2018

1 reference

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

Cancer. p53, guardian of the genome

21 January 2018

1 reference

Wild-type p53 can inhibit oncogene-mediated focus formation

21 January 2018

1 reference

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

21 January 2018

1 reference

Translating p53 into the clinic.

21 January 2018

1 reference

Awakening guardian angels: drugging the p53 pathway

21 January 2018

1 reference

Mutant p53 gain-of-function in cancer

21 January 2018

1 reference

21 January 2018

p53: guardian of ploidy

1 reference

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 January 2018

1 reference

Recent advances in p53 research: an interdisciplinary perspective.

21 January 2018

1 reference

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

21 January 2018

1 reference

Presence of a potent transcription activating sequence in the p53 protein

21 January 2018

1 reference

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

Transcriptional control of human p53-regulated genes

21 January 2018

1 reference

The role of mutant p53 in human cancer

21 January 2018

1 reference

Targeting p53 to mitochondria for cancer therapy

21 January 2018

1 reference

Pharmacological reactivation of mutant p53: from protein structure to the cancer patient

21 January 2018

1 reference

Pharmacological activation of p53 in cancer cells

21 January 2018

1 reference

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy

21 January 2018

1 reference

Small-molecule inhibitors of MDM2 as new anticancer therapeutics

21 January 2018

1 reference

The DNA-damage response in human biology and disease

21 January 2018

1 reference

Apoptosis regulation in tetraploid cancer cells

21 January 2018

1 reference

Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.

21 January 2018

1 reference

Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis

21 January 2018

1 reference

Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin

21 January 2018

1 reference

Mitotic catastrophe: a mechanism for avoiding genomic instability.

21 January 2018

1 reference

Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints

21 January 2018

1 reference

Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability

21 January 2018

1 reference

Selective killing of p53-deficient cancer cells by SP600125.

21 January 2018

1 reference

Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine

21 January 2018

1 reference

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

The spindle-assembly checkpoint in space and time

21 January 2018

1 reference

Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway

21 January 2018

1 reference

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

21 January 2018

1 reference

Dedifferentiation of lineage-committed cells by a small molecule

21 January 2018

1 reference

Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy

21 January 2018

1 reference

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

21 January 2018

1 reference

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

21 January 2018

1 reference

Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells

21 January 2018

1 reference

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

21 January 2018

1 reference

Targeting the cancer kinome through polypharmacology

21 January 2018

1 reference

Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer

21 January 2018

1 reference

Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines

21 January 2018

1 reference

Cell death assays for drug discovery

21 January 2018

1 reference

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

21 January 2018

1 reference

Mitochondrial control of cell death induced by hyperosmotic stress

21 January 2018

1 reference

A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib

21 January 2018

1 reference

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone

21 January 2018

1 reference

Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells

21 January 2018

1 reference

Caspase independence of radio-induced cell death

21 January 2018

1 reference